Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Diabetisk retinopati hos type 1-diabetikere i Frederiksborg Amt
Engelsk titel: Diabetic retinopathy in type 1 diabetics in the county of Frederiksborg Läs online Författare: Jacobsen N ; Kjer BE ; Goldschmidt E ; Ortved Andersen O ; Thorsteinsson B Språk: Dan Antal referenser: 16 Dokumenttyp: Artikel UI-nummer: 03071089

Tidskrift

Ugeskrift for Laeger 2003;165(30)2953-6 ISSN 0041-5782 E-ISSN 1603-6824 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

Introduction: Screening for diabetic retinopathy in a Danish county - are we following the recommendations? Incidence and risk factors of development and progression of diabetic retinopathy and prevalence of blindness among type 1 diabetics consulting the hospital of Hillerød are being described. Material and methods: A total of 223 type 1 diabetics (debut <30 years of age, insulin treated from first year of diagnosis) identified in a cross-sectional study in 1993 and followed until 2000 when data from last examination in the diabetes out-patient clinic and the ophthalmology clinic are registered. Results: Ophthalmologists have screened nearly 97% of the patients as stated in the recommendations of the department. Only 2% were blind and only one patient went blind during the study period. The incidence of development of retinopathy was (54/119) 45%, (14/104) 13% had improved, (77/194) 40% had a progression of retinopathy, and (30/194) 15% had progressed to proliferative retinopathy. Risk factors found in the study match previously described risk factors. Discussion: Audits encourage the implementation of screening programmes and hence reduce sight threatening diabetic retinopathy. The results of the study emphasize the importance of close co-operation between diabetes out-patient clinics and ophthalmologists and the necessity of regular screening. More audits are needed to bring screening for diabetic eye disease into focus and decrease the number of weak-sighted and blind diabetics.